ReShape Lifesciences Announces Formation of International Scientific Advisory Board
23 3월 2023 - 9:30PM
ReShape Lifesciences Inc. (Nasdaq:
RSLS), the premier physician-led weight loss and metabolic
health-solutions company, today announced the formation of a
Scientific Advisory Board (SAB). Members include internationally
recognized experts and surgeons in the obesity and metabolic
disease fields. The newly created SAB will provide management with
strategic input and external scientific review of the company’s
development activities and product pipeline.
“The establishment of a SAB will provide us
access to an extensive and unparalleled knowledge base as well as
relationships and insights that will be invaluable as we continue
to execute on our disciplined approach to drive revenue and expand
our product pipeline, including our next-generation Lap-Band® 2.0,
which we expect to submit to the U.S. Food and Drug Administration
for approval during the first half of this year,” stated Paul
F. Hickey, President and Chief Executive Officer of ReShape
Lifesciences. “The members of this advisory board will play a
critical role as we help expand access for patients to safe and
effective treatments for durable weight loss, improvements in
obesity related comorbidities and quality of life.”
Jaime Ponce, M.D., Medical Director of the CHI
Memorial Hospital’s Weight Management Center in Chattanooga, TN,
and current President of the International Federation for Surgery
of Obesity and Metabolic Disorders (IFSO) North America Chapter,
added, “ReShape is a strong leader in the field of weight loss and
metabolic health, with a portfolio of proven weight loss solutions
including the Lap-Band® System. I am honored to be included with
this international team of experts and look forward to
collaborating with all of the members to help guide ReShape in its
quest to increase the utilization of the Lap-Band tool, which is
backed by 25 years of clinical evidence and is the only FDA
approved laparoscopic weight loss device on the U.S. market.”
Members of the ReShape SAB include:
- Caroline Apovian,
M.D., is the Co-Director at the Center for Weight
Management and Wellness in the Division of Endocrinology, Diabetes
and Hypertension at Brigham and Women’s Hospital in Boston, MA, and
a Professor of Medicine at Harvard Medical School. Dr. Apovian won
the Distinguished Leader in Obesity Medicine award from the
American Board of Obesity Medicine in 2020.
- Michael Baptista,
M.D., is a bariatric, general and laparoscopic
surgeon affiliated with the Bariatric Center of Excellence Memorial
Hospital Jacksonville in Florida. Dr. Baptista is a published
author in the weight loss field and has given many courses, both on
how to perform bariatric surgery, and how to follow up with
patients afterwards.
- Matt Brengman,
M.D., is a board-certified general and bariatric surgeon
practicing in Richmond and Fredericksburg, VA. Dr. Brengman
pioneered the practice of advanced laparoscopy and laparoscopic
bariatric surgery while at Walter Reed Army Medical Center. He is
an active member of the American Society for Metabolic and
Bariatric Surgery (ASMBS), currently serving as At-Large member of
the Executive Council.
- John Dixon – MBBS,
Ph.D., is currently an adjunct professor at the Iverson
Health Innovation Research Institute, Swinburne University in
Melbourne, Australia. He has focused on obesity research for over
20 years. He has published more than 300 research manuscripts and
has been involved in all aspects of clinical obesity research, and
in education and policy development.
- Francesco Furbetta,
M.D., is a specialist in surgery of the digestive system
and digestive endoscopies. He developed an interdisciplinary
treatment of obesity and, since 1996, has been teaching Lap-Band
training courses. He is a Professor of the Postgraduate Course in
Laparoscopic Surgery at the University of Bari in Italy, a member
of IFSO and a former director of the Italian Society of Obesity
Surgery.
- Darrin Hansen,
M.D., is currently a fellow of the American College of
Surgeons and a member of the ASMBS. He is a Center of Excellence
Surgeon for the Lap-Band procedure. He has also organized and
instituted a research study on resolution for type 2 diabetic
Lap-Band patients.
- Michael Orris,
D.O., is a founding partner and lead surgeon at the Weight
Loss Institute of Arizona and AZ Weight Loss Clinic. He currently
serves as Chief Executive Officer of Advanced Surgical Weight Loss
and is associate clinical professor at Midwestern University. Dr.
Orris is a fellow of the ASMBS.
- Carl Pesta, D.O.,
is the Medical Director of the McLaren Macomb Bariatric Surgery
Institute as well as a fellow with the American College of
Osteopathic Surgeons. He is currently a member and fellow of the
ASMBS and president of the ASMBS foundation. He is past president
of the Michigan Bariatric Society.
- Jaime Ponce, M.D.,
is the Medical Director for the CHI Memorial’s Weight Management
Center in Chattanooga, TN and current president of the IFSO North
America Chapter and a member of the IFSO Executive Board. Dr. Ponce
is a fellow of the American College of Surgeons as well as the
ASMBS and is past president of the ASMBS and a founding member of
the of the ASMBS Tennessee State Chapter.
- Christine Ren-Fielding,
M.D., is currently the Professor of Surgery at NYU School
of Medicine as well as the Director of the NYU Langone Weight
Management Program and Chief of the Division of Bariatric Surgery.
She is chairman of the membership committee of the NY State Chapter
of ASMBS and recently won the Excellence in Clinical Care Award
from the organization in 2022.
- Adam Smith, D.O.,
is a Bariatric Surgery Specialist and Chief Executive Officer of
Ultimate Bariatrics in Fort Worth, TX. He is currently Chairman of
Bariatric Surgery at Baylor Scott and White Medical Center Trophy
Club and Associate Professor at University of North Texas Health
Sciences Center. He is a member of ASMBS, is a surgical trainer for
Lap-Band and has also been a Lap-Band patient, himself. Dr. Smith
has lectured internationally on topics including obesity and the
Lap-Band system.
- Shaw Somers M.D.,
FRCS, is a specialist Upper GI and Bariatric Surgeon at
Streamline Surgical UK. He is past President of the British Obesity
and Metabolic Surgery Society, council member of the association of
Upper GI Surgery, and council member of the Parliamentary Advisory
Group on Obesity.
- Erik Wilson, M.D.,
is presently the Medical Director of Bariatric Surgery at Memorial
Hermann-Texas Medical Center, Professor of Surgery at the
University of Texas Medical School at Houston, as well as the
Director of the Minimally Invasive Surgeons of Texas (MIST). He is
the Co-Founder of the Texas Association of Bariatric Surgery and is
a Southeast Regional Board Member.
About ReShape Lifesciences
Inc.
ReShape Lifesciences® is America’s premier
weight loss and metabolic health-solutions company, offering an
integrated portfolio of proven products and services that manage
and treat obesity and metabolic disease. The proprietary,
FDA-approved, Lap-Band® System provides minimally invasive,
long-term treatment of obesity and is an alternative to more
invasive surgical stapling procedures such as the gastric bypass or
sleeve gastrectomy. ReShapeCare™ is a virtual weight-management
program that supports lifestyle changes for all weight loss
patients led by board-certified health coaches to help them keep
the weight off over time. The recently launched ReShape
Marketplace™ is an online collection of quality wellness products
curated for all consumers to help them achieve their health goals.
The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™)
system utilizes a proprietary vagus nerve block and stimulation
technology platform for the treatment of Type 2 diabetes and
metabolic disorders. The patented, Obalon® balloon technology
is a non-surgical, swallowable, gas-filled intra-gastric balloon
that is designed to provide long-lasting weight loss. For more
information, please visit www.reshapelifesciences.com.
Contacts
ReShape Lifesciences Investor Contact:Thomas
StankovichChief Financial
Officer949-276-6042ir@ReShapeLifesci.com
Investor Relations Contact:Rx Communications
GroupMichael Miller917-633-6086mmiller@rxir.com
ReShape Lifesciences (NASDAQ:RSLS)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
ReShape Lifesciences (NASDAQ:RSLS)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024